Skip to main content
. 2015 Mar 19;5:9329. doi: 10.1038/srep09329

Figure 5. Palladium-mediated activation of Pro-FUdR in HCT116 cells under hypoxic conditions.

Figure 5

Treatments: untreated cells (negative control); Pd0-resins (0.67 mg/mL, negative control); 0.03–30 μM of Pro-FUdR (negative control); 0.03–30 μM of FUdR (positive control); and Pd0-resin (0.67 mg/mL) + 0.03–30 μM of Pro-FUdR (BOOM activation assay). Cell viability was determined at day 5 using the PrestoBlue™ reagent (Life Technologies) and a microplate reader. Error bars: ±SD from n = 3.